Health Care [ 3/12 ] | Biotechnology [ 13/73 ]
NASDAQ | Common Stock
Enveric Biosciences, Inc., a biotechnology company, engages in the development of small-molecule therapeutics for the treatment of anxiety, depression, and addiction disorders.
The company offers product candidates are EB-002, an active metabolite of psilocybin, which is in preclinical development stage for the treatment of anxiety disorders; and EB-003 that is in preclinical development stage for the treatment mental health.
It also focuses on the development of cannabinoid conjugate molecules for the treatment of pain and cancer.
The company is headquartered in Naples, Florida.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| May 13, 25 | -4.82 Decreased by -1.05 K% | -0.40 Decreased by -1.10 K% |
| Mar 24, 25 | -0.17 Increased by +88.48% | -0.23 Increased by +26.39% |
| Nov 11, 24 | -0.24 Increased by +81.58% | -0.52 Increased by +53.94% |
| Aug 12, 24 | -0.25 Increased by +91.78% | -0.55 Increased by +54.55% |
| May 15, 24 | -0.42 Increased by +90.08% | -0.77 Increased by +45.45% |
| Mar 26, 24 | -1.47 Increased by +40.49% | -1.54 Increased by +4.55% |
| Nov 13, 23 | -1.30 Increased by +52.38% | -2.09 Increased by +37.80% |
| Aug 11, 23 | -3.04 Increased by +43.18% | -0.65 Decreased by -367.69% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Mar 31, 25 | 0.00 Decreased by N/A% | -2.18 M Increased by +11.07% | Decreased by N/A% Decreased by N/A% |
| Dec 31, 24 | 0.00 Decreased by -100.00% | -3.15 M Increased by +8.19% | Decreased by N/A% Decreased by N/A% |
| Sep 30, 24 | 0.00 Decreased by N/A% | -2.08 M Increased by +26.16% | Decreased by N/A% Decreased by N/A% |
| Jun 30, 24 | 0.00 Decreased by N/A% | -1.88 M Increased by +70.46% | Decreased by N/A% Decreased by N/A% |
| Mar 31, 24 | 0.00 Decreased by N/A% | -2.46 M Increased by +46.79% | Decreased by N/A% Decreased by N/A% |
| Dec 31, 23 | 647.09 K Increased by +N/A% | -3.44 M Increased by +75.55% | Decreased by -530.98% Decreased by N/A% |
| Sep 30, 23 | 0.00 Decreased by N/A% | -2.82 M Decreased by -510.96% | Decreased by N/A% Decreased by N/A% |
| Jun 30, 23 | 0.00 Decreased by N/A% | -6.36 M Decreased by -621.90% | Decreased by N/A% Decreased by N/A% |